Merck’s $5.9 Billion Bet on Terns Pharma Aims to Offset Keytruda Patent Cliff
🎧 Listen:By Peter Loftus | March 25, 2026Merck’s $5.9 Billion Terns Deal Marks a Strategic Push Into Leukemia as Keytruda Faces ...
Tag: Terns Pharmaceuticals
🎧 Listen:By Peter Loftus | March 25, 2026Merck’s $5.9 Billion Terns Deal Marks a Strategic Push Into Leukemia as Keytruda Faces ...